Insights

Acquired Growth Infirst Healthcare was acquired by Carlin Consumer Health in October 2023, signaling potential for enhanced distribution, expanded channel access, and accelerated go-to-market capabilities that sales teams can leverage for broader market reach.

Trusted Pediatric Brands Portfolio includes Mylicon, Mylanta, and Dr. Cocoa, brands with physician and consumer trust in pediatric and family health spaces, presenting clear cross-sell opportunities to retailers and healthcare partners seeking established consumer healthcare lines.

Mid‑Market Footprint Smaller company scale with high growth potential and available funding, suggesting an opportunity for channel partners to provide strategic support, manufacturing scale, and distribution expertise to accelerate market penetration.

Digital & E‑commerce Readiness Current tech stack includes WordPress and email services, indicating a digital foundation ripe for optimization, e-commerce integration, and data-driven marketing partnerships to boost online visibility and direct-to-consumer sales.

North America Focus Westport, CT base with pediatric consumer health portfolio aligns with U.S. retail and pharmacy channels; potential sales opportunities exist with retailers, distributors, and healthcare providers seeking reputable, ready-to-market pediatric OTC brands.

Similar companies to Infirst Healthcare

Infirst Healthcare Tech Stack

Infirst Healthcare uses 8 technology products and services including RSS, WordPress, CookieYes, and more. Explore Infirst Healthcare's tech stack below.

Infirst Healthcare's Email Address Formats

Infirst Healthcare uses at least 3 email formats:
Infirst Healthcare Email FormatsExamplePercentage
First.Last@infirst-usa.comJohn.Doe@infirst-usa.com
77%
Last@infirst-usa.comDoe@infirst-usa.com
23%
First.Last@infirst.co.ukJohn.Doe@infirst.co.uk
100%

Frequently Asked Questions

What is Infirst Healthcare's official website and social media links?

Minus sign iconPlus sign icon
Infirst Healthcare's official website is infirst-usa.com and has social profiles on LinkedIn.

How much revenue does Infirst Healthcare generate?

Minus sign iconPlus sign icon
As of August 2026, Infirst Healthcare's annual revenue is estimated to be $1M - $10M.

What is Infirst Healthcare's NAICS code?

Minus sign iconPlus sign icon
Infirst Healthcare's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Infirst Healthcare have currently?

Minus sign iconPlus sign icon
As of August 2026, Infirst Healthcare has approximately 9 employees across 2 continents, including Europe and North America. Key team members include Chief Customer Officer: P. M., President - North America: T. B. and Director, Drug Development & Consumer Marketing: K. S. Explore Infirst Healthcare's employee directory with LeadIQ.

What industry does Infirst Healthcare belong to?

Minus sign iconPlus sign icon
Infirst Healthcare operates in the Pharmaceutical Manufacturing industry.

What technology does Infirst Healthcare use?

Minus sign iconPlus sign icon
Infirst Healthcare's tech stack includes RSS, WordPress, CookieYes, Amazon Simple Email Service, Microsoft 365, WP Engine, PHP and HTTP/3.

What is Infirst Healthcare's email format?

Minus sign iconPlus sign icon
Infirst Healthcare's email format typically follows the pattern of First.Last@infirst-usa.com. Find more Infirst Healthcare email formats with LeadIQ.

How much funding has Infirst Healthcare raised to date?

Minus sign iconPlus sign icon
As of August 2026, Infirst Healthcare has raised $39M in funding. The last funding round occurred on Mar 31, 2017.

When was Infirst Healthcare founded?

Minus sign iconPlus sign icon
Infirst Healthcare was founded in 2013.
Infirst Healthcare logo

Infirst Healthcare

Pharmaceutical ManufacturingConnecticut, United States2-10 Employees

Infirst Healthcare Inc. operates in pharmaceutical manufacturing, focusing on developing and commercializing established drugs with improvements. Based in Westport, Connecticut, it maintains a small, agile team that aims to address underserved consumer healthcare needs. Its product portfolio includes Mylicon for infant gas relief, Mylanta as a leading liquid antacid, and Dr. Cocoa, a pediatric cough and cold medicine made with 10% real cocoa. Within the consumer healthcare segment, the company emphasizes enhancements to established medicines by applying cross-category insights. In October 2023, Carlin Consumer Health acquired Infirst USA Holdings, LLC.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2013
Employees
2-10

Section iconFunding & Financials

  • $39M

    Infirst Healthcare has raised a total of $39M of funding over 2 rounds. Their latest funding round was raised on Mar 31, 2017 as a Venture Round.

  • $1M - $10M

    Infirst Healthcare's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.